Summary
To determine whether E-643, a new α-blocking agent, would reduce the blood pressure, regardless of the posture, a 1 mg dose was given 3 times daily for 7 consecutive days, to 8 male and 7 female inpatients, aged 37–73 years, with essential hypertension. Blood pressure and pulse rate were measured daily in the supine, sitting and standing positions. Before and after the treatment with E-643, plasma levels of noradrenaline, adrenaline, dopamine-β-hydroxylase, renin and aldosterone were determined, samples being obtained with the subjects recumbent and after standing upright for 60 min. A significant reduction in the systolic and diastolic blood pressures was evident in the supine (172±31/100±12 → 151±28/89±14 mmHg), sitting (158±22/101±11 → 138±28/89±15 mmHg) and standing (153±32/103±21 → 129±31/89±20 mmHg) positions. The reduction in blood pressure remained unchanged throughout the period of administration of E-643. Pulse rate was not affected when the subjects were supine (67±10 → 69±10 beats/min), but was increased in the sitting (68±10 → 73±9 beats/min) and standing (73±10 → 81±11 beats/min) positions. The increased pulse rate tended to decline during continued administration of E-643. Treatment with E-643 produced no significant change in plasma levels of adrenaline, noradrenaline, dopamine-β-hydroxylase, renin and aldosterone. The antihypertensive effect of treatment was more prominent in the patients with higher levels of plasma catecholamines and dopamine-β-hydroxylase, and was less prominent in those with higher plasma renin and aldosterone. Two patients had temporary bouts of dizziness and visual disturbances, but there were no subjective complaints during treatment.
Similar content being viewed by others
References
Berthelsen S, Pettinger WA (1977) A functional basis for classification of α-adrenergic receptors. Life Sci 21: 595–606
Cambridge D, Devey MJ, Massingham R (1977) Prazosin, a selective antagonist of postsynaptic alpha-adrenoreceptors. Br J Pharmacol 59: 514p-515p
Chiba S, Furukawa Y, Watanabe H (1981) Chronotropic and inotropic effects of three kinds of alpha-adrenergic blockers on the isolated dog atria. Jpn Heart J (In press)
Cubeddu LX, Barnes EM, Langer SZ, Weiner N (1974) Release of norepinephrine and dopamine-β-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of alpha presynaptic receptors. J Pharmacol Exp Ther 190: 431–450
Drew GM (1977) Pharmacological characterization of the presynaptic α-adrenoceptor in the rat vas deferens. Eur J Pharmacol 42: 123–130
Hickler RB, Hamlin JT, Wells Jr RE (1959) Plasma norepinephrine response to tilting in essential hypertension. Circulation 20: 422–426
Igarashi T, Nakajima Y, Ohtake S (1976) Comparison of effects of α-blocking agents on blood pressure and heart rate in unanesthetized spontaneously hypertensive (SHR) and normotensive rats. Clin Exp Pharmacol Physiol (Suppl) 3: 89–92
Igarashi T, Nakajima Y, Ohtake S (1977) Antihypertensive effect of combined treatment with α- and β-adrenergic blockers in the spontaneously hypertensive rat. Jpn Circ J 41: 903–911
Imura O, Shoji T, Okada T, Miyama A, Kijima T, Yoshida S, Imai M, Kondo A, Miyahara M (1979) Sympathetic nerve activity in low renin essential hypertension. Jpn Circ J 43: 870–881
Kawasaki T, Kumamoto K, Fukiyama K, Noda Y, Takishita S, Omae T (1979) Individual renin-aldosterone responses of clinically healthy young Japanese men to dietary sodium and posture. Jpn Heart J 20: 631–642
Kumamoto K, Fukiyama K, Noda Y, Kawasaki T, Takishita S, Omae T (1979) Renin response to upright posture in varying sodium balance in normal young Japanese men. Jpn Heart J 20: 777–788
Langer SZ (1974) Presynaptic regulation of catecholamine release. Biochem Pharmacol 23: 1793–1800
Mori N, Yamanishi Y, Saeki T, Yamatsu K, Igarashi T (1981) Effect of a newly developed alpha-adrenergic blocking compound, E-643, on catecholamine turnover (in Japanese). Nippon Yakurigaku Zasshi (In press)
Mulvihill-Wilson J, Graham RM, Pettinger WA, Muckleroy C, Anderson S, Gaffney FA, Blomqvist CG (1979) Comparative effects of prazosin and phenoxybenzamine on arterial blood pressure, heart rate, and plasma catecholamine in essential hypertension. J Cardiovasc Pharmacol 1 (Suppl): S1-S7
Nagatsu T, Udenfriend S (1972) Photometric assay of dopamine-β-hydroxylase activity in human blood. Clin Chem 18: 980–983
Roach AG, Dennis T, Scatton B, Gavero I (1979) Contribution of cardiac presynaptic alpha-adrenoceptors to the clonidine-induced bradycardia in dogs. In: Langer SZ, Starke K, Dubocovich ML (eds) Presynaptic receptors. Pergamon Press, Oxford, pp 53–57
Shoij T, Daiku Y, Igarashi T (1980) Alpha-adrenoceptor blocking properties of a new antihypertensive agent, 2-[4-(n-butyryl)-homopipe-razine-lyl]-4-amino-6, 7-dimethoxy-quinazoline (E-643). Jpn J Pharmacol 30: 763–772
Shoji T (1981) Comparison of pre- and postynaptic alphaadrenoceptor blocking effect of E-643 in the isolated vas deferens of the rat. Jpn J Pharmacol 31: 361–368
Starke K (1972) Alpha-symphatomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart. Naunyn Schmiedeberg's Arch Pharmacol 272: 18–45
Takishita S, Fukiyama K, Kumamoto K, Noda Y, Kawasaki T, Omae T (1977) Plasma dopamine-beta-hydroxylase activity in normal young men: Its responsiveness to manipulation of sodium balance and upright posture. Jpn Circ J 41: 895–901
Tamiya T, Takatsuka K, Kumamoto Y, Aoyama T, Taguchi G (1976) Application of precise accumulation method to analysis of survival-time data: Statistical evaluation of estrogen therapy for prostatic cancer (Abstract in English). Rinsho-Yakuri (Clin Pharmacol) 7: 403–414
Weitzell R, Tanaka T, Starke K (1979) Pre- and postsynaptic effects of yohimbin. Stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit. Naunyn Schmiedeberg's Arch Pharmacol 308: 127–136
Wikberg JES (1979) The pharmacological classification of adrenergic α1 and α2 receptors and their mechanism of action. Acta Physiol Scand (Suppl) 468: 1–99
Yui Y, Fujita T, Yamamoto T, Itokawa Y, Kawai C (1980) Liquid-chromatographic determination of norepinephrine and epinephrine in human plasma. Clin Chem 26: 194–196
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kawasaki, T., Uezono, K., Abe, I. et al. Antihypertensive effect of E-643, a new alpha-adrenergic blocking agent. Eur J Clin Pharmacol 20, 399–405 (1981). https://doi.org/10.1007/BF00542090
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542090